These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
781 related articles for article (PubMed ID: 31520915)
1. Helenalin from Centipeda minima ameliorates acute hepatic injury by protecting mitochondria function, activating Nrf2 pathway and inhibiting NF-κB activation. Li Y; Zeng Y; Huang Q; Wen S; Wei Y; Chen Y; Zhang X; Bai F; Lu Z; Wei J; Lin X Biomed Pharmacother; 2019 Nov; 119():109435. PubMed ID: 31520915 [TBL] [Abstract][Full Text] [Related]
2. Protective Role of 4-Octyl Itaconate in Murine LPS/D-GalN-Induced Acute Liver Failure via Inhibiting Inflammation, Oxidative Stress, and Apoptosis. Li R; Yang W; Yin Y; Zhang P; Wang Y; Tao K Oxid Med Cell Longev; 2021; 2021():9932099. PubMed ID: 34457120 [TBL] [Abstract][Full Text] [Related]
3. Andrographolide ameliorates d-galactosamine/lipopolysaccharide-induced acute liver injury by activating Nrf2 signaling pathway. Pan CW; Yang SX; Pan ZZ; Zheng B; Wang JZ; Lu GR; Xue ZX; Xu CL Oncotarget; 2017 Jun; 8(25):41202-41210. PubMed ID: 28465482 [TBL] [Abstract][Full Text] [Related]
4. Oxyresveratrol prevents lipopolysaccharide/d-galactosamine-induced acute liver injury in mice. Jia YN; Lu HP; Peng YL; Zhang BS; Gong XB; Su J; Zhou Y; Pan MH; Xu L Int Immunopharmacol; 2018 Mar; 56():105-112. PubMed ID: 29414639 [TBL] [Abstract][Full Text] [Related]
5. Protective effects of morin on lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting TLR4/NF-κB and activating Nrf2/HO-1 signaling pathways. Tian Y; Li Z; Shen B; Zhang Q; Feng H Int Immunopharmacol; 2017 Apr; 45():148-155. PubMed ID: 28213269 [TBL] [Abstract][Full Text] [Related]
6. Curcumin attenuates lipopolysaccharide/d-galactosamine-induced acute liver injury by activating Nrf2 nuclear translocation and inhibiting NF-kB activation. Xie YL; Chu JG; Jian XM; Dong JZ; Wang LP; Li GX; Yang NB Biomed Pharmacother; 2017 Jul; 91():70-77. PubMed ID: 28448872 [TBL] [Abstract][Full Text] [Related]
7. Nobiletin attenuates lipopolysaccharide/D‑galactosamine‑induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF‑κB‑mediated cytokine production. He Z; Li X; Chen H; He K; Liu Y; Gong J; Gong J Mol Med Rep; 2016 Dec; 14(6):5595-5600. PubMed ID: 27878238 [TBL] [Abstract][Full Text] [Related]
8. Maresin 1 protects against lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting macrophage pyroptosis and inflammatory response. Yang W; Tao K; Zhang P; Chen X; Sun X; Li R Biochem Pharmacol; 2022 Jan; 195():114863. PubMed ID: 34861244 [TBL] [Abstract][Full Text] [Related]
9. Propofol attenuates inflammatory response and apoptosis to protect d-galactosamine/lipopolysaccharide induced acute liver injury via regulating TLR4/NF-κB/NLRP3 pathway. Zhang Z; Tian L; Jiang K Int Immunopharmacol; 2019 Dec; 77():105974. PubMed ID: 31735662 [TBL] [Abstract][Full Text] [Related]
10. Protective effect of tormentic acid from Potentilla chinensis against lipopolysaccharide/D-galactosamine induced fulminant hepatic failure in mice. Lin X; Zhang S; Huang R; Tan S; Liang S; Wu X; Zhuo L; Huang Q Int Immunopharmacol; 2014 Apr; 19(2):365-72. PubMed ID: 24560903 [TBL] [Abstract][Full Text] [Related]
11. Role of α-lipoic acid in LPS/d-GalN induced fulminant hepatic failure in mice: studies on oxidative stress, inflammation and apoptosis. Xia X; Su C; Fu J; Zhang P; Jiang X; Xu D; Hu L; Song E; Song Y Int Immunopharmacol; 2014 Oct; 22(2):293-302. PubMed ID: 25046589 [TBL] [Abstract][Full Text] [Related]
12. Protective Effects of Sesquiterpenoids from the Root of Panax ginseng on Fulminant Liver Injury Induced by Lipopolysaccharide/d-Galactosamine. Wang W; Zhang Y; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J J Agric Food Chem; 2018 Jul; 66(29):7758-7763. PubMed ID: 29974747 [TBL] [Abstract][Full Text] [Related]
13. Hepatoprotective effect of chiisanoside from Acanthopanax sessiliflorus against LPS/D-GalN-induced acute liver injury by inhibiting NF-κB and activating Nrf2/HO-1 signaling pathways. Bian X; Liu X; Liu J; Zhao Y; Li H; Zhang L; Li P; Gao Y J Sci Food Agric; 2019 May; 99(7):3283-3290. PubMed ID: 30552777 [TBL] [Abstract][Full Text] [Related]
14. 4-hydroxybenzo[d]oxazol-2(3H)-one ameliorates LPS/D-GalN-induced acute liver injury by inhibiting TLR4/NF-κB and MAPK signaling pathways in mice. Wang H; Wei X; Wei X; Sun X; Huang X; Liang Y; Xu W; Zhu X; Lin X; Lin J Int Immunopharmacol; 2020 Jun; 83():106445. PubMed ID: 32272395 [TBL] [Abstract][Full Text] [Related]
15. Madecassoside prevents acute liver failure in LPS/D-GalN-induced mice by inhibiting p38/NF-κB and activating Nrf2/HO-1 signaling. Wang W; Wu L; Li Q; Zhang Z; Xu L; Lin C; Gao L; Zhao K; Liang F; Zhang Q; Zhou M; Jiang W Biomed Pharmacother; 2018 Jul; 103():1137-1145. PubMed ID: 29715757 [TBL] [Abstract][Full Text] [Related]
17. Protective effects of tenuigenin on lipopolysaccharide and d-galactosamine-induced acute liver injury. Jia R; Zhang H; Zhang W; Zhao H; Zha C; Liu Y Microb Pathog; 2017 Nov; 112():83-88. PubMed ID: 28958948 [TBL] [Abstract][Full Text] [Related]
18. Isoliquiritigenin alleviates LPS/ D-GalN-induced acute liver failure by activating the PGC-1α/ Nrf2 pathway to reduce oxidative stress and inflammatory response. Wang L; Wang X; Kong L; Wang S; Huang K; Wu J; Wang C; Sun H; Liu K; Meng Q Int Immunopharmacol; 2021 Nov; 100():108159. PubMed ID: 34555641 [TBL] [Abstract][Full Text] [Related]
19. Modulation of the crosstalk between Keap1/Nrf2/HO-1 and NF-κB signaling pathways by Tomatidine protects against inflammation/oxidative stress-driven fulminant hepatic failure in mice. Abdulaal WH; Omar UM; Zeyadi M; El-Agamy DS; Alhakamy NA; Ibrahim SRM; Almalki NAR; Asfour HZ; Al-Rabia MW; Mohamed GA; Elshal M Int Immunopharmacol; 2024 Mar; 130():111732. PubMed ID: 38402834 [TBL] [Abstract][Full Text] [Related]
20. Endotoxin tolerance ameliorates lipopolysaccharide/D-galactosamine-induced acute liver failure by negative regulation of the NF-κB/NLRP3 and activation of Nrf2/HO-1 via Sitr1. Shi H; Xie X; Zheng S; Chen H; Liu C; Li S; Lu M Int Immunopharmacol; 2024 May; 132():111994. PubMed ID: 38581992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]